Skip to Main Content

Paper Details

Decreased Antibody Responses to Ad26.COV2.S Relative to SARS-CoV-2 mRNA Vaccines in Patients With Inflammatory Bowel Disease.
Gastroenterology
29
2021
Inflammatory Bowel Disease, Patients, SARS, SARS-, SARS-CoV-2 mRNA
Author NameAffiliation
Jonathan BraunInflammatory Bowel and Immunobiology Research Institute, Cedars-Sinai Medical Center
Jonathan BraunInflammatory Bowel and Immunobiology Research Institute, Cedars-Sinai Medical Center
Dermot P B McGovernInflammatory Bowel and Immunobiology Research Institute, Cedars-Sinai Medical Center
Dermot P B McGovernInflammatory Bowel and Immunobiology Research Institute, Cedars-Sinai Medical Center
Gil Y MelmedInflammatory Bowel and Immunobiology Research Institute, Cedars-Sinai Medical Center
Christina HaInflammatory Bowel and Immunobiology Research Institute, Cedars-Sinai Medical Center
Gaurav SyalInflammatory Bowel and Immunobiology Research Institute, Cedars-Sinai Medical Center
Susan ChengSmidt Heart Institute
Brigid S BolandUniversity of California
Brigid S BolandUniversity of California
Nimisha K ParekhUniversity of California irvine
Corey A SiegelDartmouth-Hitchcock Medical Center
  • 1 - 12

Datasets

Release 1.2